Programmable base editing of mutated TERT promoter inhibits brain tumour growth
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Programmable base editing of mutated TERT promoter inhibits brain tumour growth
Authors
Keywords
-
Journal
NATURE CELL BIOLOGY
Volume 22, Issue 3, Pages 282-288
Publisher
Springer Science and Business Media LLC
Online
2020-02-18
DOI
10.1038/s41556-020-0471-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CRISPResso2 provides accurate and rapid genome editing sequence analysis
- (2019) Kendell Clement et al. NATURE BIOTECHNOLOGY
- Analysis and minimization of cellular RNA editing by DNA adenine base editors
- (2019) Holly A. Rees et al. Science Advances
- Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis
- (2019) Changyang Zhou et al. NATURE
- Continuous evolution of base editors with expanded target compatibility and improved activity
- (2019) Benjamin W. Thuronyi et al. NATURE BIOTECHNOLOGY
- CRISPR DNA base editors with reduced RNA off-target and self-editing activities
- (2019) Julian Grünewald et al. NATURE BIOTECHNOLOGY
- CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
- (2019) Lei Xu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Stabilization of Reversed Replication Forks by Telomerase Drives Telomere Catastrophe
- (2018) Pol Margalef et al. CELL
- Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling
- (2018) Barbara Oldrini et al. Nature Communications
- Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
- (2018) Johnny H. Hu et al. NATURE
- ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner
- (2018) Jacqueline A. Brosnan-Cashman et al. PLoS One
- Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway
- (2018) Qixue Wang et al. Theranostics
- Crystal Structure of the Minimal Cas9 from Campylobacter jejuni Reveals the Molecular Diversity in the CRISPR-Cas9 Systems
- (2017) Mari Yamada et al. MOLECULAR CELL
- Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy
- (2017) Xinjian Li et al. MOLECULAR CELL
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
- (2017) Ryan D Chow et al. NATURE NEUROSCIENCE
- Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis
- (2016) Xinjian Li et al. MOLECULAR CELL
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- (2016) Hao Yin et al. NATURE BIOTECHNOLOGY
- A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation
- (2016) Xinjian Li et al. NATURE CELL BIOLOGY
- Role of Telomeres and Telomerase in Aging and Cancer
- (2016) J. W. Shay Cancer Discovery
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
- (2015) R. J. A. Bell et al. SCIENCE
- Cancer-associated TERT promoter mutations abrogate telomerase silencing
- (2015) Kunitoshi Chiba et al. eLife
- In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
- (2014) Lukasz Swiech et al. NATURE BIOTECHNOLOGY
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
- (2013) Lei S. Qi et al. CELL
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
- (2013) Luke A. Gilbert et al. CELL
- CRISPR RNA–guided activation of endogenous human genes
- (2013) Morgan L Maeder et al. NATURE METHODS
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
- (2012) Weiwei Yang et al. NATURE CELL BIOLOGY
- Glioblastoma: From Molecular Pathology to Targeted Treatment
- (2011) Timothy F. Cloughesy et al. Annual Review of Pathology-Mechanisms of Disease
- Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
- (2011) Weiwei Yang et al. NATURE
- Altered Telomeres in Tumors with ATRX and DAXX Mutations
- (2011) C. M. Heaphy et al. SCIENCE
- Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations
- (2011) Jill Wykosky et al. Chinese Journal of Cancer
- Different outcomes of telomere-dependent anaphase bridges
- (2010) Laura Tusell et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth
- (2010) C. O. Marian et al. CLINICAL CANCER RESEARCH
- Alternative lengthening of telomeres: models, mechanisms and implications
- (2010) Anthony J. Cesare et al. NATURE REVIEWS GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now